3

OWNERSHIP DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: June 23, 2020
Period of Report: June 10, 2020
Accession Number: 0001104659-20-076172

View Document ↗ View on SEC.gov ↗